Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Inv. presentation
Director departure
Cara Therapeutics, Inc. (CARA) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/07/2023 8-K Investor presentation
Docs: "Corporate Presentation August 2023"
08/07/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/07/2023 8-K Quarterly results
Docs: "Cara Therapeutics Reports Second Quarter 2023 Financial Results"
08/03/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Cara Therapeutics Appoints Helen M. Boudreau to Board of Directors"
07/25/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
07/07/2023 SC 13G/A BlackRock Inc. reports a 6.9% stake in CARA THERAPEUTICS INC
04/20/2023 ARS Form ARS - Annual Report to Security Holders:
04/20/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/20/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
03/23/2023 8-K Investor presentation
Docs: "Corporate Presentation March 2023"
03/10/2023 8-K Regulation FD Disclosure  Interactive Data
03/06/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
03/06/2023 10-K Annual Report for the period ended December 31, 2022
03/06/2023 8-K Quarterly results
Docs: "Cara Therapeutics Announces Fourth Quarter and Full Year 2022 Financial Results"
01/20/2023 SC 13G/A BlackRock Inc. reports a 14.4% stake in CARA THERAPEUTICS INC
01/09/2023 8-K Investor presentation
Docs: "Corporate Presentation"
11/18/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
11/07/2022 8-K Investor presentation
Docs: "2 30 0K 3 M 12 M"
11/07/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/07/2022 8-K Quarterly results
Docs: "Cara Therapeutics Reports Third Quarter 2022 Financial Results"
11/03/2022 8-K Quarterly results
09/12/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "254 Canoe Hill Road New Canaan, CT 06840",
"Cara Therapeutics Appoints Ryan Maynard as Chief Financial Officer"
08/08/2022 10-Q Quarterly Report for the period ended June 30, 2022
08/08/2022 8-K Quarterly results
08/08/2022 8-K Quarterly results
06/30/2022 8-K Quarterly results
06/07/2022 8-K Quarterly results
06/03/2022 8-K Quarterly results
05/12/2022 EFFECT Form EFFECT - Notice of Effectiveness:
05/09/2022 S-3/A Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
05/09/2022 10-Q Quarterly Report for the period ended March 31, 2022
05/09/2022 8-K Quarterly results
Docs: "Cara Therapeutics Reports First Quarter 2022 Financial Results"
04/22/2022 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/22/2022 DEF 14A Form DEF 14A - Other definitive proxy statements:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy